InspireMD Selling General Administrative vs Operating Income Analysis

NSPR Stock

USD 3.00 0.02 0.67%

InspireMD financial indicator trend analysis is infinitely more than just investigating InspireMD recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether InspireMD is a good investment. Please check the relationship between InspireMD Selling General Administrative and its Operating Income accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

Selling General Administrative vs Operating Income

Selling General Administrative vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of InspireMD Selling General Administrative account and Operating Income. At this time, the significance of the direction appears to have no relationship.

The correlation between InspireMD's Selling General Administrative and Operating Income is 0.09. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Operating Income in the same time period over historical financial statements of InspireMD, assuming nothing else is changed. The correlation between historical values of InspireMD's Selling General Administrative and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of InspireMD are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Selling General Administrative i.e., InspireMD's Selling General Administrative and Operating Income go up and down completely randomly.

Correlation Coefficient

0.09

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Selling General Administrative

Operating Income

Operating Income is the amount of profit realized from InspireMD operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of InspireMD is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from InspireMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InspireMD current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.At this time, InspireMD's Tax Provision is relatively stable compared to the past year. As of 12/23/2024, Sales General And Administrative To Revenue is likely to grow to 2.31, while Issuance Of Capital Stock is likely to drop slightly above 27.4 M.

	2021	2022	2023	2024 (projected)
Cost Of Revenue	3.7M	4.1M	4.4M	3.1M
Research Development	5.2M	7.8M	8.0M	4.3M

Cost Of Revenue Research Development

InspireMD fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Property Plant And Equipment Gross	Short Term Debt	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable
Total Assets		0.59	0.11	0.97	-0.57	-0.57	0.34	0.97	0.18	0.92	0.49	0.08	1.0	-0.35	-0.12	0.64	0.17	0.26	0.05	0.26	0.88	-0.28	0.61	0.82	-0.36	0.21
Other Current Liab	0.59		0.43	0.48	-0.1	-0.26	0.29	0.51	0.42	0.5	0.35	0.49	0.58	-0.08	0.23	0.79	0.47	0.4	0.38	0.68	0.54	-0.15	0.58	0.59	-0.03	0.25
Total Current Liabilities	0.11	0.43		-0.07	0.43	-0.1	0.02	0.14	-0.21	0.12	0.11	0.7	0.11	-0.48	0.7	0.37	0.52	0.01	0.46	0.22	0.09	0.78	0.27	0.05	0.15	0.43
Total Stockholder Equity	0.97	0.48	-0.07		-0.66	-0.63	0.27	0.96	0.15	0.91	0.56	-0.14	0.97	-0.34	-0.33	0.58	-0.01	0.22	-0.13	0.17	0.89	-0.4	0.61	0.83	-0.45	0.14
Net Debt	-0.57	-0.1	0.43	-0.66		0.47	-0.57	-0.64	-0.13	-0.43	-0.49	0.36	-0.59	0.1	0.46	-0.37	-0.03	-0.29	0.07	0.01	-0.46	0.58	-0.42	-0.47	0.53	-0.17
Retained Earnings	-0.57	-0.26	-0.1	-0.63	0.47		0.12	-0.68	0.35	-0.65	-0.94	0.35	-0.55	0.67	0.42	-0.66	0.03	0.29	0.27	0.3	-0.74	0.06	-0.85	-0.79	0.91	0.01
Cash	0.34	0.29	0.02	0.27	-0.57	0.12		0.33	0.26	0.03	-0.04	0.45	0.37	0.05	0.36	0.27	0.49	0.41	0.55	0.26	0.02	-0.24	0.12	0.02	0.05	0.49
Cash And Short Term Investments	0.97	0.51	0.14	0.96	-0.64	-0.68	0.33		0.04	0.9	0.6	0.02	0.97	-0.47	-0.14	0.68	0.23	0.26	0.08	0.14	0.87	-0.21	0.68	0.8	-0.49	0.28
Common Stock Total Equity	0.18	0.42	-0.21	0.15	-0.13	0.35	0.26	0.04		0.0	-0.26	0.13	0.17	0.6	-0.08	0.16	0.08	0.54	0.12	0.81	0.05	-0.46	-0.1	0.15	0.44	0.01
Common Stock Shares Outstanding	0.92	0.5	0.12	0.91	-0.43	-0.65	0.03	0.9	0.0		0.52	-0.05	0.91	-0.37	-0.21	0.55	0.01	0.11	-0.11	0.17	0.97	-0.18	0.56	0.83	-0.41	0.06
Other Stockholder Equity	0.49	0.35	0.11	0.56	-0.49	-0.94	-0.04	0.6	-0.26	0.52		-0.34	0.47	-0.65	-0.45	0.72	0.01	-0.18	-0.25	-0.2	0.61	-0.12	0.91	0.71	-0.86	0.07
Total Liab	0.08	0.49	0.7	-0.14	0.36	0.35	0.45	0.02	0.13	-0.05	-0.34		0.1	0.0	0.95	0.25	0.76	0.28	0.85	0.42	-0.09	0.45	-0.03	-0.14	0.45	0.46
Total Current Assets	1.0	0.58	0.11	0.97	-0.59	-0.55	0.37	0.97	0.17	0.91	0.47	0.1		-0.35	-0.09	0.62	0.18	0.29	0.08	0.25	0.86	-0.28	0.59	0.79	-0.34	0.26
Common Stock	-0.35	-0.08	-0.48	-0.34	0.1	0.67	0.05	-0.47	0.6	-0.37	-0.65	0.0	-0.35		-0.02	-0.41	-0.07	0.33	0.09	0.46	-0.35	-0.42	-0.6	-0.38	0.56	-0.26
Short Long Term Debt Total	-0.12	0.23	0.7	-0.33	0.46	0.42	0.36	-0.14	-0.08	-0.21	-0.45	0.95	-0.09	-0.02		0.03	0.69	0.14	0.82	0.21	-0.27	0.6	-0.2	-0.34	0.48	0.45
Non Current Assets Total	0.64	0.79	0.37	0.58	-0.37	-0.66	0.27	0.68	0.16	0.55	0.72	0.25	0.62	-0.41	0.03		0.52	0.27	0.33	0.32	0.67	-0.09	0.87	0.79	-0.49	0.28
Non Currrent Assets Other	0.17	0.47	0.52	-0.01	-0.03	0.03	0.49	0.23	0.08	0.01	0.01	0.76	0.18	-0.07	0.69	0.52		0.45	0.95	0.31	0.03	0.31	0.28	0.04	0.04	0.48
Net Receivables	0.26	0.4	0.01	0.22	-0.29	0.29	0.41	0.26	0.54	0.11	-0.18	0.28	0.29	0.33	0.14	0.27	0.45		0.49	0.71	0.08	-0.35	-0.09	0.05	0.41	0.53
Non Current Liabilities Total	0.05	0.38	0.46	-0.13	0.07	0.27	0.55	0.08	0.12	-0.11	-0.25	0.85	0.08	0.09	0.82	0.33	0.95	0.49		0.35	-0.11	0.27	0.01	-0.13	0.26	0.51
Inventory	0.26	0.68	0.22	0.17	0.01	0.3	0.26	0.14	0.81	0.17	-0.2	0.42	0.25	0.46	0.21	0.32	0.31	0.71	0.35		0.18	-0.22	-0.04	0.17	0.52	0.3
Property Plant And Equipment Gross	0.88	0.54	0.09	0.89	-0.46	-0.74	0.02	0.87	0.05	0.97	0.61	-0.09	0.86	-0.35	-0.27	0.67	0.03	0.08	-0.11	0.18		-0.22	0.66	0.93	-0.51	0.0
Short Term Debt	-0.28	-0.15	0.78	-0.4	0.58	0.06	-0.24	-0.21	-0.46	-0.18	-0.12	0.45	-0.28	-0.42	0.6	-0.09	0.31	-0.35	0.27	-0.22	-0.22		-0.02	-0.3	0.14	0.07
Other Liab	0.61	0.58	0.27	0.61	-0.42	-0.85	0.12	0.68	-0.1	0.56	0.91	-0.03	0.59	-0.6	-0.2	0.87	0.28	-0.09	0.01	-0.04	0.66	-0.02		0.78	-0.73	0.05
Property Plant And Equipment Net	0.82	0.59	0.05	0.83	-0.47	-0.79	0.02	0.8	0.15	0.83	0.71	-0.14	0.79	-0.38	-0.34	0.79	0.04	0.05	-0.13	0.17	0.93	-0.3	0.78		-0.59	-0.05
Current Deferred Revenue	-0.36	-0.03	0.15	-0.45	0.53	0.91	0.05	-0.49	0.44	-0.41	-0.86	0.45	-0.34	0.56	0.48	-0.49	0.04	0.41	0.26	0.52	-0.51	0.14	-0.73	-0.59		0.12
Accounts Payable	0.21	0.25	0.43	0.14	-0.17	0.01	0.49	0.28	0.01	0.06	0.07	0.46	0.26	-0.26	0.45	0.28	0.48	0.53	0.51	0.3	0.0	0.07	0.05	-0.05	0.12

Click cells to compare fundamentals

InspireMD Account Relationship Matchups

InspireMD fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.9M	17.8M	39.7M	24.7M	47.6M	50.0M
Other Current Liab	2.1M	3.1M	3.0M	4.0M	4.5M	2.7M
Total Current Liabilities	3.1M	3.7M	4.3M	5.1M	6.0M	4.2M
Total Stockholder Equity	5.4M	12.2M	33.5M	17.4M	39.5M	41.5M
Net Debt	(4.9M)	(11.6M)	(10.8M)	(3.0M)	(9.6M)	(9.2M)
Retained Earnings	(157.6M)	(168.2M)	(183.1M)	(201.6M)	(221.5M)	(210.4M)
Cash	5.5M	12.6M	12.0M	4.6M	9.6M	7.6M
Cash And Short Term Investments	5.5M	12.6M	34.0M	17.8M	39.0M	41.0M
Common Stock Shares Outstanding	139.3K	1.5M	7.3M	7.9M	24.3M	25.5M
Liabilities And Stockholders Equity	9.9M	17.8M	39.7M	24.7M	47.6M	50.0M
Other Stockholder Equity	163.0M	180.3M	216.6M	219.0M	261M	138.1M
Total Liab	4.5M	5.6M	6.2M	7.3M	8.1M	6.9M
Total Current Assets	7.8M	15.3M	37.1M	21.3M	44.2M	46.4M
Non Current Assets Total	2.1M	2.4M	2.6M	3.3M	3.5M	2.0M
Non Currrent Assets Other	586K	725K	905K	856K	951K	654.2K
Net Receivables	973K	945K	1.4M	1.2M	1.8M	1.0M
Non Current Liabilities Total	1.4M	1.9M	1.8M	2.2M	2.1M	2.1M
Inventory	1.2M	1.4M	1.1M	1.6M	2.1M	1.2M
Property Plant And Equipment Gross	421K	1.5M	1.7M	2.5M	4.6M	4.8M
Other Liab	729K	910K	1.1M	995K	1.1M	738.6K
Property Plant And Equipment Net	421K	1.5M	1.7M	2.5M	2.5M	2.7M
Accounts Payable	646K	236K	893K	659K	939K	570.7K
Other Assets	586K	725K	905K	856K	984.4K	506K
Retained Earnings Total Equity	(140.4M)	(147.6M)	(157.6M)	(168.2M)	(151.4M)	(158.9M)
Other Current Assets	87K	334K	522K	655K	3.0M	3.2M
Property Plant Equipment	547K	448K	1.7M	2.5M	2.8M	3.0M
Net Tangible Assets	5.4M	12.2M	33.5M	17.4M	20.0M	21.0M
Capital Surpluse	143.1M	156.4M	163.0M	180.3M	207.4M	157.7M
Non Current Liabilities Other	624K	605K	1.4M	1.9M	2.2M	2.3M
Net Invested Capital	5.4M	12.2M	33.5M	17.4M	39.5M	41.5M

Pair Trading with InspireMD

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InspireMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InspireMD will appreciate offsetting losses from the drop in the long position's value.

Moving together with InspireMD Stock

0.64	EW	Edwards Lifesciences Corp	Pair Corr
0.69	GH	Guardant Health	Pair Corr

Moving against InspireMD Stock

0.63	ENSG	Ensign Group	Pair Corr
0.62	DRIO	DarioHealth Corp	Pair Corr
0.6	EDAP	EDAP TMS SA	Pair Corr
0.49	VTAK	Catheter Precision	Pair Corr
0.49	EKSO	Ekso Bionics Holdings	Pair Corr

The ability to find closely correlated positions to InspireMD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InspireMD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InspireMD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InspireMD to buy it.

The correlation of InspireMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InspireMD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InspireMD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for InspireMD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC